| Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge | International Journal of Stroke | 2021 | 130 |
| Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals | Gut | 2021 | 80 |
| Efficacy of Dulaglutide Expanded Doses by Baseline A1C Categories: Post Hoc Analysis of AWARD-11 | Journal of the Endocrine Society | 2021 | 78 |
| Circulating HMGB1 Levels Are Associated With Glucose Clamp-Derived Measures of Insulin Resistance in Women With PCOS | Journal of the Endocrine Society | 2021 | 78 |
| Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study | Journal of Allergy and Clinical Immunology | 2021 | 77 |
| Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions | Journal of Neurology, Neurosurgery and Psychiatry | 2021 | 67 |
| Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review | EClinicalMedicine | 2021 | 63 |
| Levels of burn-out among healthcare workers during the COVID-19 pandemic and their associated factors: a cross-sectional study in a tertiary hospital of a highly burdened area of north-east Italy | BMJ Open | 2021 | 61 |
| Muscle Strength and Physical Performance in Patients Without Previous Disabilities Recovering From COVID-19 Pneumonia | American Journal of Physical Medicine and Rehabilitation | 2021 | 56 |
| Coronavirus Disease 2019-Associated Coagulopathy | Mayo Clinic Proceedings | 2021 | 50 |
| Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials | Metabolites | 2021 | 50 |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses | Clinical Infectious Diseases | 2021 | 50 |
| Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2-Related Encephalitis: The ENCOVID Multicenter Study | Journal of Infectious Diseases | 2021 | 49 |
| Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease | Lancet Neurology, The | 2021 | 47 |
| What We Have Learned from Two Decades of Epidemics and Pandemics: A Systematic Review and Meta-Analysis of the Psychological Burden of Frontline Healthcare Workers | Psychotherapy and Psychosomatics | 2021 | 46 |
| The impact of the Covid-19 pandemic on customer experience design: The hotel managers' perspective | International Journal of Hospitality Management | 2021 | 45 |
| Clinicogenomic Analysis of -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib | Cancer Discovery | 2021 | 45 |
| Astrocytic interleukin-3 programs microglia and limits Alzheimer's disease | Nature | 2021 | 41 |
| Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination | Diagnostics | 2021 | 40 |
| Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis | Journal of Dermatological Treatment | 2021 | 38 |
| Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis | Clinical Microbiology and Infection | 2021 | 37 |
| Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) | Annals of the Rheumatic Diseases | 2021 | 36 |
| COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak | JACC: Heart Failure | 2021 | 36 |
| Endoscopic Ultrasound-guided Fine-needle Biopsy With or Without Rapid On-site Evaluation for Diagnosis of Solid Pancreatic Lesions: A Randomized Controlled Non-Inferiority Trial | Gastroenterology | 2021 | 36 |
| Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11) | Diabetes Care | 2021 | 36 |
